Enanta Pharmaceuticals
ENTA
#7451
Rank
$0.42 B
Marketcap
$14.60
Share price
3.62%
Change (1 day)
82.27%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2025 (TTM): $64.8 Million USD

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is $64.8 Million USD. In 2024 the company made a revenue of $66.59 Million USD a decrease over the revenue in the year 2023 that were of $73.62 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $64.8 M-2.68%
2024 $66.59 M-9.55%
2023 $73.62 M-10.32%
2022 $82.09 M-11.7%
2021 $92.97 M-8.53%
2020 $0.10 B-45.9%
2019 $0.18 B-21.19%
2018 $0.23 B82.68%
2017 $0.13 B159.77%
2016 $50.24 M-61.89%
2015 $0.13 B6.02%
2014 $0.12 B2344.39%
2013 $5.08 M-92.61%
2012 $68.82 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
$59.64 B 91,934.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$92.14 B 142,092.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$11.72 B 17,989.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$64.23 B 99,018.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$48.03 B 74,019.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$56.37 B 86,885.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland